Russian anti-Ebola vaccines ready for human trials
Russia’s N.F. Gamalei Epidemiology and Microbiology Research Institute has launched clinical trials of anti-Ebola vaccines that will necessitate 4.8 million rubles (about $75,000), the official portal for government procurement said on Friday. Pre-emptive vaccines against Ebola – Gum Evak and Gum Evak Combi are ready for human trials, the portal said. The main aim of the research is to assess post-vaccination immunity in...
Cuba Develops New Vaccines for Human Use
Cuban institutions member of the group of Biotechnological and Pharmaceutical Industries (Bio Cuba Farma) announced of the development of new vaccines that strengthen security and efficient indicators in pre-clinical research of the population. Among the innovations is a quadrivalent formula to combat dengue, carried out by the Center for Genetic Engineering and Biotechnology (CIGB). They are also working in various solutions...
Recent posts
